Contrarius Group Holdings »

Crispr Therapeutics shares owned by Contrarius Group Holdings

Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by Contrarius Group Holdings from 13F filings

Historical chart of Contrarius Group Holdings investment in Crispr Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Crispr Therapeutics held by Contrarius Group Holdings consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Crispr Therapeutics by Contrarius Group Holdings

Quarter filed Position value Share count Share price at filing
2025-09-30 $18M 270k 64.81
2025-06-30 $18M 375k 48.64
2025-03-31 $11M 332k 34.03